The Contribution of Endothelial Marker Proteins in the Determination of Vascular Angiogenic Potential, in Normal Physiological Conditions and in Neoplasia

Open access

Summary

Recently, the most significant studies in the field of angiogenesis are related to trials concerning the evaluation of the prognostic significance of endothelial markers. By using an estimation of the expression of endothelial cell markers, immunohistochemical studies can assess for the continuity of the vascular intima, as well as allow for the distinction of early, late and mature forms of endothelial cells. The determination of the endothelial cell phenotype using markers such as CD34, CD31, CD133, e-NOS and von Willebrand factor may provide a valuable tool for the monitoring of both normal physiology as well as neoplastic diseases.

If the inline PDF is not rendering correctly, you can download the PDF file here.

  • [1] BARAŃSKA P JERCZYŃSKA H PAWŁOWSKA Z. Czynnik wzrostu śródbłonka naczyń - budowa i funkcje. Postępy Biochem 2005; 51: 13-21.

  • [2] BECKER R LENTER MC VOLLKOMMER T BOOS AM PFAFF D AUGUSTIN HG CHRISTIAN S. Tumor stroma marker endosialin (Tem1) is a binding partner of metastasis - related protein Mac-2 BP/90K. FASEB J 2008; 22: 3059-67.

  • [3] BERGRES G BENJAMIN L. Tumorigenesis and the angiogenic switch. Net Rev Cancer 2003; 3 (6): 401-410.

  • [4] CAPETTINI LS CORTES SF GOMES MA SILVA GA PESQUERO JL LOPES MJ TEIXEIRA MM LEMOS VS. Neuronal nitric oxide synthase-derived hydrogen peroxide is a major endothelium-dependent relaxing factor. Am J Physiol Heart Circ Physiol 2008; 295: H2503-H2511.

  • [5] CHAN YC LEUNG FP WONG WT TIAN XY YUNG LM LAU CW TSANG SY YAO X CHEN ZY HUANG Y. Therapeutically relevant concentrations of raloxifene dilate pressurized rat resistance arteries via calcium-dependent endothelial nitric oxide synthase activation. Arterioscler Thromb Vasc Biol 2010; 30: 992-999.

  • [6] CHRISTIAN S WINKLER R HELFRICH I Boos AM BESEMFELDER E SCHADENDORF D AUGUSTIN HG. Endosialin (Tem1) is a marker of tumor-associated myofibroblasts and tumor vessel-associated mural cells. Am J Pathol 2008; 172: 486-94.

  • [7] CIERNIEWSKI CS. Regulacja angiogenezy - nowa broń onkologii. Biol Molek 2006; 1 (5): 20-22.

  • [8] DANESHTALAB N SMEDA JS. Alterations in the modulation of cerebrovascular tone and blood flow by nitric oxide synthases in SHRsp with stroke. Cardiovasc Res 2010; 86: 160-168.

  • [9] DAVIES G RMALI KA WATKINS G MANSEL RE MASON MD JIANG. Elevated levels of tumour endothelial marker-8 in human breast cancer and its clinical significance. Int J Oncol 2006; 29: 1311-7.

  • [10] DEANFIELD JE HALCOX JP RABELINK TJ. Endothelial function and dysfunction: testing and clinical relevance. Circulation 2007; 115 (10): 1285-1295.

  • [11] DENIS CV. Molecular and cellular biology of von Willebrand factor. Int J Hematol 2002; 75: 3-8.

  • [12] DIAS FA URBONIENE D YUZHAKOVA MA. Ablation of iNOS delays cardiac contractile dysfunction in chronic hypertension. Front Biosci 2010; 2: 312-24.

  • [13] DIGNAT-GEORGE F SAMPOL J. Circulation endothelial cells in vascular disordes: new insights into an old concept. Eur J Haematol 2000; 65: 215-220.

  • [14] FUCHS B MAHLUM E HALDER C. High expression of tumor endothelial marker 7 is associated with metastasis and poor survival of patients with osteogenic sarcoma. Gene 2007; 399: 137-43.

  • [15] FÜRSTENBERGER G VON MOOS R LUCAS R THÜRLIMANN B SENN H HAMACHER J BOENEBERG EM: Circulating endothelial cells and angiogenic serum factors during neoadiuvant chemotherapy of primary breast cancer. Br J Cancer 2006; 94: 524-531.

  • [16] GOOK PK LIP GY BOOS CJ STONELAKE PS BLANN AD. Circulating endothelial cells endothelial progenitor cells and endothelial microparticles in cancer. Neoplasia 2006; 8 (2): 79-88.

  • [17] HAI-FENG D XIAN-WEN H JIN-LONG C LI-HUA G. Antitumor Activities of TEM8-Fc: An Engineered Antibody-like Molecule Targeting Tumor Endothelial Marker 8. J Natl Cancer Inst 2007; 99 (20): 1551-1555.

  • [18] HALDER C OSSENDORF C MARAN A YASZEMSKI M BOLANDER ME FUCHS B SARKAR G. Preferential Expression of the Secreted and Membrane forms of Tumor Endothelial Marker 7 transcripts in Osteosarcoma. Anticancer Res 2009; N; 29 (11): 4317-4322.

  • [19] HRISTOV M WEBER C. Endothelial progenitor cells: characterization pathophysiology and possible clinical relevance. J Cell Mol Med 2004; 8 (4): 498-508.

  • [20] KHNYTKIN D TROEN G BERNER JN. The expression of fibroblast growth factors and their receptors in Hodgkin’s lymphoma. J Pathol 2006; 208 (3): 431-438.

  • [21] KLUZ J ADAMIEC R. Krążące komórki śródbłonka w zapalnych chorobach naczyń. Adv Clin Exp Med 2007; 16 (1): 95-104.

  • [22] KRAUSE DS FACKLER MJ CIVIN CI MAY WS. CD34: structure biology and clinical utility. Blood 1996 ; 1: 87 (1): 1-13.

  • [23] LEE JH PALAIA T RAGOLIA L. Impaired insulin-mediated vasorelaxation in diabetic Goto- Kakizaki rats is caused by impaired Akt phosphorylation. Am J Physiol Cell Physiol 2009; 296: C327-38.

  • [24] KOPCZYŃSKA E. Śródbłonkowe markery nowotworowe. Współczesna Onkologia 2008; 12 6: 255-260.

  • [25] LEKONSTEVA O CHAKRABARTI S JIANG Y CHEUNG CC DAVIDGE ST. Role of Neuronal Nitric Oxide Synthase in Estrogen-Induced Relaxation in Rat Resistance Arteries. J Pharmacol Exp Ther 2011. JPET Fast Forward. Published on August 1 2011 as DOI:10.1124/jpet.111.183798

  • [26] MELIKAN N SEDDON MD CASADEI B CHOWIENCZYK PJ SHAH AM. Neuronal nitric oxide synthase and human vascular regulation. Trends Cardiovasc Med 2009; 19: 256-262.

  • [27] MEREGALLI M FARINI A BELICCHI M TORRENTE Y. CD133(+) cells isolated from various sources and their role in future clinical perspectives. Expert Opin Biol Ther 2010; 10 (11): 1521-8.

  • [28] MIZIA-MALARZ M SOBOL G WOŚ H. Angiogeneza w przewlekłych schorzeniach zapalnych i nowotworowych. Pol Merkuriusz Lek 2008; XXIV 141: 185-189.

  • [29] MOZAFFARIAN D WILSON PW KANNEL WB. Beyond established and novel risk factors: lifestyle risk factors for cardiovascular disease. Circulation 2008; 117 (23): 3031-3038.

  • [30] NAGAREDDY PR SOLIMAN H LIN G. Selective inhibition of protein kinase C beta(2) attenuates inducible nitric oxide synthase-mediated cardiovascular abnormalities in streptozotocin-induced diabetic rats. Diabetes 2009; 58: 2355-64.

  • [31] NANDA A KARIM B PENG Z. Tumor endothelial marker 1 (TEM1) functions in the growth and progression of abdominal tumors. PNAS 2006; 103: 3351-6.

  • [32] NEWMAN PJ ALBELDA SM. Cellular and molecular aspects of PECAM-1. Nouv Rev Fr Hematol 1992; 34 Suppl: S9-13.

  • [33] NICO B BENAGIANO V MANGIERI D MARUOTTI N VACCA A RIBATTI D. Evaluation of microvascular density in tumors: pro and contra. Histol Histopathol 2008 May; 23 (5): 601-7.

  • [34] NOWICKI M MISTERSKI M MALINSKA A PEREK B OSTALSKA-NOWICKA D JEMIELITY M WITKIEWICZ W ZABEL M. Endothelial integrity of radial artery grafts harvest by minimally invasive surgery - immunohistochemical studies of CD 31 and endothelial nitric oxide synthase expression: a randomized trial. Eur J Cardiothorac Surg 2011; 39: 471-477.

  • [35] OWOC-LEMPACH J CHYBICKA A. Znaczenie angiogenezy w nowotworach występujących w populacji dziecięcej. Onkol Pol 2006; 9 (3): 87-92.

  • [36] PADUCH R. Przerzut nowotworowy - znaczenie agregacji komórek nowotworowych z płytkami krwi. Onkol Pol 2005; 8 4: 229-238.

  • [37] PAUTZ A ART J HAHN S. Regulation of the expression of inducible nitric oxide synthase. Nitric Oxide 2010; 23: 75-93.

  • [38] PRIVRATSKY JR PADDOCKCM FLOREY O NEWMAN DK MULLER WA NEWMAN PJ. Relative contribution of PECAM-1 adhesion and signaling to the maintenance of vascular integrity. J Cell Sci 2011; 124: 1477-85.

  • [39] RIBATTI D. The involvement of endothelial progenitor cells in tumor angiogenesis.: J Cell Mol Med 2004; 8: 294-300.

  • [40] RIBATTI D MARIMPIETRI D PASTORINO F BRIGNOLE C NICO B VACCA A PONZONI M. Angiogenesis in Neuroblastoma. Ann NY Acad Sci 2004; 1028: 133-142.

  • [41] SAGRINATI C NETTI GS MAZZINGHI B LAZZERI E LIOTTA F FROSALI F RONCONI E MEINI C GACCI M SQUECCO R CARINI M GESUALDO L FRANCINI F MAGGI E ANNUNZIATO F LASAGNI L SERIO M ROMAGNANI S ROMAGNANI P. Isolation and characterization of multipotent progenitor cells from the Bowman's capsule of adult human kidneys. J Am Soc Nephrol 2006; 17 (9): 2443-56.

  • [42] SEDDON M MELIKIAN N DWORAKOWSKI R SHABEEH H JIANG B BYRNE J CASADEI B CHOWIENCZYK P SHAH AM. Effects of neuronal nitric oxide synthase on human coronary artery diameter and blood flow in vivo. Circulation 2009; 119: 2656-2662.

  • [43] SIMONAVICIUS N ROBERTSON D BAX DA JONES C HUIJBERS IJ ISACKE CM. Endosialin (CD248) is a marker of tumor-associated pericytes in high-grade glioma. Mod Pathol 2008; 21: 308-15.

  • [44] SKÓRA J BIEGUS J PUPKA A BARĆ P SIKORA J SZYBER P. Molekularne podstawy angiogenezy. Postępy Hig Med Dośw 2006; 60: 410-415.

  • [45] SOSKIĆ SS DOBUTOVIC BD SUDAR EM OBRADOVIĆ MM NIKOLIĆ DM DJORDJEVIC JD RADLAK DJ MIKHAILIDIS DP ISENOVIĆ ER. Regulation of Inducible Nitric Oxide Synthase (iNOS) and its Potential Role in Insulin Resistance Diabetes and Heart Failure. Open Cardiovasc Med J 2011; 5: 153-163.

  • [46] SUDAR E DOBUTOVIC B SOSKIE S. Regulation of inducible nitric oxide synthase activity/expression in rat hearts from ghrelin-treated rats. The Open Cardiovascular Medicine Journal 2011; 5: 153-163.

  • [47] SUGIURA T DOHI Y TAKASE H YAMASHITA S TANAKA S KIMURA G. Increased reactive oxygen metabolites is associated with cardiovascular risk factors and vascular endothelial damage in middle-aged Japanese subjects. Vasc Health Risk Manag 2011; 7: 475-482.

  • [48] ŚWIDZIŃSKA E NAUMNIK W CHYCZEWSKA E. Angiogeneza i neoangiogeneza - znaczenie w raku płuca i innych nowotworach. Pneumonol Alergol Pol 2006; 74: 414-420.

  • [49] TOMKOWICZ B RYBINSKI K FOLEY B. Interaction of endosialin/TEM1 with extracellular matrix proteins mediates cell adhesion and migration. PNAS 2007; 104: 17965-70.

  • [50] VALLON M ESSLER M. Proteolytically processed soluble tumor endothelial marker (TEM) 5 mediates endothelial cell survival during angiogenesis by linking integrin alpha(v)beta3 to glycosaminoglycans. J Biochem 2006; 281 (45): 34179-88.

  • [51] VANHOUTTE PM SHIMOKAWA H TANG EH FELETOU M. Endothelial dysfunction and vascular disease. Acta Physiol Hung 2009; 196 (2): 193-222.

  • [52] WALSKI M FRONTCZAK-BANIEWICZ M. Cechy ultrastrukturalne prawidłowego i dysfunkcyjnego śródbłonka naczyń krwionośnych. Pol Arch Med Wewn 2007; 117 (Supl.): 46-49.

  • [53] WERNER E KOWALCZYK AP FAUNDEZ V. Anthrax toxin receptor 1/tumor endothelium marker 8 mediates cell spreading by coupling extracellular ligands to the actin cytoskeleton. J Biol Chem 2006; 281: 23227-36.

  • [54] WHITE AR RYOO S LI D. Knockdown of arginase I restores NO signaling in the vasculature of old rats. Hypertension 2006; 47: 245-51.

  • [55] WNUCZKO K SZCZEPAŃSKI N. Śródbłonek-charakterystyka i funkcje. Pol Merkuriusz Lek 2007; XXIII 133: 60-65.

  • [56] WOYWODT A BAHLMANN F DE GROOT K HALLER H HAUBITZ M. Circulation endothelial cells: life death detachment and repair of the endothelial cell layer. Nephrol Dial Transplant 2002; 17: 1728-1730.

  • [57] WRÓBEL T MAZUR G DZIĘGIEL P. Density of intranodal lymphatics and VEGF-C expression in B-cell lymphoma and reactive lymph nodes. Folia Histochem Cytobiol 2006; 44: 43-47.

  • [58] WRÓBEL T. PORĘBA M. MAZUR G. Angiogenic and coagulation - fibrinolysis factors in non- Hodgkin’s lymphoma. Neoplasma 2006; 53: 253-258.

  • [59] YUAN J OSSENDORF C SZATKOWSKI JP BRONK JT MARAN A YASZEMSKI M BOLANDER ME SARKAR G FUCHS B. Osteoblastic and osteolytic human osteosarcomas can be studied with a new xenograft mouse model producing spontaneous metastases. Cancer Invest 2009; 27: 435-442.

  • [60] ZAKULA Z KORICANAC G PUTNIKOVIC B MARKOVIC L ISENOVIC ER. Regulation of the inducible nitric oxide synthase and sodium pump in type 1 diabetes. Med Hypotheses 2007; 69: 302-306.

  • [61] ZHANG P XU X HU X. Inducible nitric oxide synthase deficiency protects the heart from systolic overload-induced ventricular hypertrophy and congestive heart failure. Circ Res 2007; 100: 1089-98.

Search
Journal information
Cited By
Metrics
All Time Past Year Past 30 Days
Abstract Views 0 0 0
Full Text Views 291 163 1
PDF Downloads 93 67 0